Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. ПироговаfiledCriticalНаучно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. Пирогова
Priority to UAU201214786UpriorityCriticalpatent/UA81216U/en
Publication of UA81216UpublicationCriticalpatent/UA81216U/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
A method for prediction of refractures in patients with false joints includes X-ray investigation, determination of content of C-reactive protein and interleukin- blood serum, and at the levels of those >7.0 mg/l and >10.1 ng/l, respectively, possibility of refracture is predicted.
UAU201214786U2012-12-242012-12-24Method for prediction of refractures in patients with false joints
UA81216U
(en)
method for predicting or monitoring whether a patient suffering from cancer or an autoimmune disease will respond or respond to treatment with a tlr-9 agonist, tlr-9 agonist for use in a cancer treatment method, and a kit to predict or monitor if a patient suffering from cancer or autoimmune disease will respond or respond to treatment with a tlr-9 agonist